HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

pertuzumab

a humanized HER-2 monoclonal antibody; prevents ERBB2 receptor protein from binding (dimerizing) to other receptors in the HER family
Also Known As:
Omnitarg; Omnitarg, 2C4; Perjeta; RG-1273; rhumab 2C4; rhumab-2C4
Networked: 926 relevant articles (166 outcomes, 336 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Swain, Sandra M: 20 articles (10/2022 - 02/2006)
2. Im, Young-Hyuck: 16 articles (10/2022 - 01/2012)
3. Clark, Emma: 16 articles (01/2022 - 01/2012)
4. Baselga, José: 16 articles (01/2021 - 03/2010)
5. Cortés, Javier: 15 articles (01/2021 - 01/2012)
6. Schneeweiss, Andreas: 14 articles (11/2020 - 03/2013)
7. Gianni, Luca: 13 articles (10/2022 - 03/2010)
8. Restuccia, Eleonora: 13 articles (05/2022 - 12/2016)
9. Ross, Graham: 13 articles (06/2016 - 01/2012)
10. Im, Seock-Ah: 12 articles (10/2022 - 01/2012)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Neoplasms (Cancer)
3. Pathologic Complete Response
4. Stomach Neoplasms (Stomach Cancer)
5. Disease Progression

Related Drugs and Biologics

1. Trastuzumab (Herceptin)
2. Docetaxel (Taxotere)
3. human ERBB2 protein
4. Ado-Trastuzumab Emtansine
5. taxane
6. Lapatinib (GW572016)
7. Monoclonal Antibodies
8. ErbB Receptors (EGF Receptor)
9. Antibodies
10. Hormones (Hormone)

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Neoadjuvant Therapy
4. Retreatment
5. Immunotherapy